Article
TRAKJAK: a complete blood count-based prediction of polycythemia vera at initial erythrocytosis workup to reduce financial and ecological costs.
The American journal of medicine - 1 Mar 2026
Rivière Etienne, Mansier Olivier, Guy Alexandre, Corcuff Jean-Benoit, Rivière Pauline, Contis Anne, Duffau Pierre, Moal Cyril Le, Mediavilla Clémence, Sibon Igor, Lazaro Estibaliz, James Chloé, Viallard Jean-François
Abstract excerpt
BACKGROUND: Erythrocytosis is common in daily clinical practice, and polycythemia vera (PV), a myeloproliferative neoplasm associated with JAK2 mutations, should be systematically considered in clinical reasoning process. Financial constraints and environmental burden of extensive testing prompted us to develop a predictive score for PV to guide decision to screen for JAK2 mutations. METHODS: We retrospectively...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
